News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,939 Results
Type
Article (87301)
Company Profile (759)
Press Release (770852)
Multimedia
Podcasts (166)
Webinars (27)
Section
Business (232999)
Career Advice (4137)
Deals (39782)
Drug Delivery (133)
Drug Development (91222)
Employer Resources (202)
FDA (18258)
Job Trends (17392)
News (397263)
Policy (39909)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (121)
Alliances (56979)
ALS (139)
Alzheimer's disease (1658)
Antibody-drug conjugate (ADC) (210)
Approvals (18264)
Artificial intelligence (466)
Autoimmune disease (51)
Automation (24)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (154)
Biotechnology (484)
Bladder cancer (120)
Brain cancer (47)
Breast cancer (453)
Cancer (3632)
Cardiovascular disease (320)
Career advice (3551)
Career pathing (36)
CAR-T (236)
CDC (52)
Cell therapy (643)
Cervical cancer (31)
Clinical research (75061)
Collaboration (1317)
Company closure (4)
Compensation (876)
Complete response letters (56)
COVID-19 (2946)
CRISPR (80)
C-suite (522)
Cystic fibrosis (130)
Data (3953)
Decentralized trials (2)
Denatured (59)
Depression (106)
Diabetes (437)
Diagnostics (7065)
Digital health (31)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (225)
Drug pricing (171)
Drug shortages (36)
Duchenne muscular dystrophy (187)
Earnings (98660)
Editorial (53)
Employer branding (25)
Employer resources (171)
Events (132532)
Executive appointments (961)
FDA (20561)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1167)
Gene editing (167)
Generative AI (45)
Gene therapy (510)
GLP-1 (1004)
Government (5359)
Grass and pollen (7)
Guidances (334)
Healthcare (20937)
HIV (48)
Huntington's disease (35)
IgA nephropathy (54)
Immunology and inflammation (231)
Immuno-oncology (19)
Indications (50)
Infectious disease (3170)
Inflammatory bowel disease (180)
Inflation Reduction Act (13)
Influenza (89)
Intellectual property (175)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (73)
Layoffs (630)
Leadership (31)
Legal (10145)
Liver cancer (91)
Longevity (12)
Lung cancer (518)
Lymphoma (252)
Machine learning (25)
Management (66)
Manufacturing (592)
MASH (124)
Medical device (14842)
Medtech (14860)
Mergers & acquisitions (22691)
Metabolic disorders (1108)
Multiple sclerosis (131)
NASH (23)
Neurodegenerative disease (198)
Neuropsychiatric disorders (53)
Neuroscience (2609)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (55)
Obesity (549)
Opinion (304)
Ovarian cancer (122)
Pain (157)
Pancreatic cancer (155)
Parkinson's disease (222)
Partnered (28)
Patents (394)
Patient recruitment (279)
Peanut (57)
People (66107)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23139)
Phase II (32600)
Phase III (24530)
Pipeline (2544)
Policy (284)
Postmarket research (3554)
Preclinical (10447)
Press Release (72)
Prostate cancer (182)
Psychedelics (51)
Radiopharmaceuticals (281)
Rare diseases (625)
Real estate (7416)
Recruiting (78)
Regulatory (27797)
Reports (64)
Research institute (2680)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (66)
Schizophrenia (123)
Series A (194)
Series B (145)
Service/supplier (30)
Sickle cell disease (78)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4315)
State (2)
Stomach cancer (17)
Supply chain (96)
Tariffs (85)
The Weekly (105)
Vaccines (1020)
Venture capital (64)
Weight loss (383)
Women's health (57)
Worklife (21)
Date
Today (7)
Last 7 days (531)
Last 30 days (2244)
Last 365 days (33690)
2025 (24478)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (79)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50847)
Australia (8931)
California (9058)
Canada (2761)
China (859)
Colorado (383)
Connecticut (405)
Delaware (248)
Europe (116803)
Florida (1331)
Georgia (306)
Hawaii (3)
Idaho (67)
Illinois (792)
India (47)
Indiana (444)
Iowa (19)
Japan (284)
Kansas (123)
Kentucky (36)
Louisiana (20)
Maine (75)
Maryland (1230)
Massachusetts (6805)
Michigan (302)
Minnesota (549)
Mississippi (4)
Missouri (114)
Montana (33)
Nebraska (26)
Nevada (104)
New Hampshire (76)
New Jersey (2503)
New Mexico (32)
New York (2470)
North Carolina (1376)
North Dakota (10)
Northern California (4042)
Ohio (283)
Oklahoma (19)
Oregon (50)
Pennsylvania (1888)
Puerto Rico (19)
Rhode Island (45)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3454)
Tennessee (144)
Texas (1413)
United States (33570)
Utah (270)
Virginia (239)
Washington D.C. (82)
Washington State (781)
West Virginia (4)
Wisconsin (94)
Wyoming (1)
There are 858,939 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Acoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CM
September 28, 2025
·
9 min read
Press Releases
MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody® sonelokimab
September 28, 2025
·
27 min read
Press Releases
Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer
September 28, 2025
·
7 min read
Press Releases
New Data from HELIOS-B Phase 3 Study Demonstrate Lower Rates of Gastrointestinal Events in ATTR-CM Patients Treated with Vutrisiran
September 28, 2025
·
13 min read
Press Releases
Larimar Therapeutics Announces Conference Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia
September 28, 2025
·
4 min read
Press Releases
Varian Elevates Halcyon Platform by Redefining the Patient Experience
September 28, 2025
·
4 min read
Press Releases
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in China
September 28, 2025
·
12 min read
Press Releases
Theralase to Present Groundbreaking Research at ASTRO 2025
Radiation-Activated Rutherrin(R) Shown to Be 100 Times More Effective Than Radiation Alone in Preclinical Cancer Models
September 26, 2025
·
7 min read
Flownamics
Catalent
1 of 85,894
Next
